<h1>Guidelines</h1>
<ul>
  <li>Recommendation: NewvoDrug is indicated for initial treatment of cardiac
  failure for all adult patients. (Strong recommendation;
  Class I, based on multiple randomized clinical trials)</li>
  <li>Contraindication: cardiac failure should never be treated with
  appendectomy in adults. (Class III, standard of care)</li>
</ul>
